Collectively, the above mentioned findings indicate that NRP-1 is a crucial regulator in breast cancer pathogenesis and might be responsible for the chemoresistance medicated by RP11-70C1.3/miR-6736-3p. The gene discussed is NRP1; the disease is breast carcinoma.